Search results
Results From The WOW.Com Content Network
Let's talk about the popular Stryker Corporation (NYSE:SYK). The company's shares led the NYSE gainers with a relatively large price hike in the past couple of weeks. With many analystsRead More...
Most readers would already know that Stryker's (NYSE:SYK) stock increased by 4.9% over the past week. Given that the...
Stryker (NYSE:SYK) has had a great run on the share market with its stock up by a significant 14% over the last three...
In 1964, the company name was changed to Stryker Corporation. [6] In 1979, Stryker made an initial public offering of stock and later acquired Osteonics Corporation, entering the replacement hip, knee, and other orthopedic implants market (Stryker). In 1999 annual sales reached $2.1 billion, and in 2000 Stryker was included in the S&P 500 and ...
For premium support please call: 800-290-4726 more ways to reach us
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern. Here's Why You Should ...
The stock of Stryker (NYSE:SYK, 30-year Financials) is believed to be modestly overvalued, according to GuruFocus Value calculation.